Statistics

Medical cannabis in the UK has grown sharply in recent years, with around 60,000 active patients in 2025 and projections to reach 100,000 before year-end. Access remains uneven, NHS prescriptions are rare, and private clinics carry the load. This guide explores patient numbers, conditions, clinics, access challenges, and how the UK compares internationally.

The UK has long been one of the world’s leading cannabis exporters, yet patients at home still face barriers to access. Using INCB data, this blog explores how much cannabis the UK exports, how it compares to Canada and other nations, the role of GW/Jazz Pharmaceuticals, and the future of domestically cultivated flower from Glass Pharms® and Dalgety.

Cannabis remains the most commonly used drug in the UK, with 6.8% of adults reporting past-year use in 2024. By the end of 2025, up to 100,000 patients are expected to be prescribed medical cannabis, while billions still flow into the illicit market. This guide explores prevalence, motivations, health impacts, arrests, costs, and the outlook for reform and patient access.

CBD is now one of the fastest-growing wellness markets in the UK. This hub gathers the latest CBD statistics for 2025, covering market size, sales, demographics, regulation and consumer trends, alongside comparisons with Europe and the US. Fresh data gives patients and the public a clear view of the UK CBD landscape.